Bio-Gene Technology Limited (BGT.AX)
AUD 0.03
(8.0%)
AUD 0.03
(8.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 3.15 Million AUD | -17.62% |
| 2023 | 3.83 Million AUD | -47.49% |
| 2022 | 7.3 Million AUD | 46.04% |
| 2021 | 5 Million AUD | -23.88% |
| 2020 | 6.56 Million AUD | 18.09% |
| 2019 | 5.56 Million AUD | -27.44% |
| 2018 | 7.66 Million AUD | -18.83% |
| 2017 | 9.44 Million AUD | 1002.99% |
| 2016 | 856.34 Thousand AUD | 96.7% |
| 2015 | 435.36 Thousand AUD | 49.62% |
| 2014 | 290.98 Thousand AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q4 | 3.15 Million AUD | 0.0% |
| 2024 Q2 | 4.29 Million AUD | 0.0% |
| 2024 FY | 3.15 Million AUD | -17.62% |
| 2023 Q2 | 5.25 Million AUD | 0.0% |
| 2023 Q4 | 3.83 Million AUD | 0.0% |
| 2023 FY | 3.83 Million AUD | -47.49% |
| 2022 Q4 | 7.3 Million AUD | 0.0% |
| 2022 FY | 7.3 Million AUD | 46.04% |
| 2022 Q2 | 6.93 Million AUD | 0.0% |
| 2021 Q2 | 5.63 Million AUD | 0.0% |
| 2021 FY | 5 Million AUD | -23.88% |
| 2021 Q4 | 5 Million AUD | 0.0% |
| 2020 Q4 | 6.56 Million AUD | 0.0% |
| 2020 FY | 6.56 Million AUD | 18.09% |
| 2020 Q2 | 4.75 Million AUD | 0.0% |
| 2019 FY | 5.56 Million AUD | -27.44% |
| 2019 Q4 | 5.56 Million AUD | 0.0% |
| 2019 Q2 | 6.39 Million AUD | 0.0% |
| 2018 Q2 | 8.46 Million AUD | 0.0% |
| 2018 FY | 7.66 Million AUD | -18.83% |
| 2018 Q4 | 7.66 Million AUD | 0.0% |
| 2017 Q4 | 3.51 Million AUD | 0.0% |
| 2017 FY | 9.44 Million AUD | 1002.99% |
| 2016 FY | 856.34 Thousand AUD | 96.7% |
| 2015 FY | 435.36 Thousand AUD | 49.62% |
| 2014 FY | 290.98 Thousand AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AdAlta Limited | 5.57 Million AUD | 43.305% |
| Acrux Limited | 8.96 Million AUD | 64.749% |
| Amplia Therapeutics Limited | 14.84 Million AUD | 78.716% |
| Biome Australia Limited | 8.27 Million AUD | 61.826% |
| BTC Health Limited | 5.14 Million AUD | 38.635% |
| Chimeric Therapeutics Limited | 15.27 Million AUD | 79.313% |
| CSL Limited | 56.93 Billion AUD | 99.994% |
| Clarity Pharmaceuticals Ltd | 154.62 Million AUD | 97.957% |
| Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 98.633% |
| Noxopharm Limited | 6.78 Million AUD | 53.424% |
| PharmAust Limited | 11.12 Million AUD | 71.599% |
| Proteomics International Laboratories Limited | 10.87 Million AUD | 70.947% |
| Prescient Therapeutics Limited | 20.39 Million AUD | 84.506% |
| PYC Therapeutics Limited | 91.23 Million AUD | 96.537% |
| Race Oncology Limited | 20.22 Million AUD | 84.381% |
| Starpharma Holdings Limited | 36.81 Million AUD | 91.417% |
| EZZ Life Science Holdings Limited | 25.55 Million AUD | 87.635% |
| Botanix Pharmaceuticals Limited | 112.46 Million AUD | 97.191% |
| Memphasys Limited | 12.43 Million AUD | 74.581% |
| Nyrada Inc. | 5.9 Million AUD | 46.513% |
| Anatara Lifesciences Ltd | 1.67 Million AUD | -89.036% |
| Telix Pharmaceuticals Limited | 398.3 Million AUD | 99.207% |
| Zelira Therapeutics Limited | 5.18 Million AUD | 39.044% |
| Patrys Limited | 4.16 Million AUD | 24.077% |
| Dimerix Limited | 32.07 Million AUD | 90.15% |
| Neuren Pharmaceuticals Limited | 247.97 Million AUD | 98.726% |
| Orthocell Limited | 26.61 Million AUD | 88.129% |
| Imugene Limited | 151.39 Million AUD | 97.913% |
| Cynata Therapeutics Limited | 8.38 Million AUD | 62.333% |
| Immutep Limited | 147.44 Million AUD | 97.857% |
| Arovella Therapeutics Limited | 13.28 Million AUD | 76.216% |
| Alterity Therapeutics Limited | 19.22 Million AUD | 83.564% |
| Nanollose Limited | 241.95 Thousand AUD | -1205.88% |
| Invex Therapeutics Ltd | 6.12 Million AUD | 48.373% |
| NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | 41.875% |
| Island Pharmaceuticals Limited | 2.56 Million AUD | -23.206% |
| Biotron Limited | 493.47 Thousand AUD | -540.272% |
| Radiopharm Theranostics Limited | 72.03 Million AUD | 95.614% |
| Tissue Repair Ltd | 19.38 Million AUD | 83.705% |
| AnteoTech Limited | 9.38 Million AUD | 66.32% |
| Hexima Limited | 2.26 Million AUD | -39.25% |
| Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | 88.465% |
| Recce Pharmaceuticals Ltd | 6.36 Million AUD | 50.396% |
| Avecho Biotechnology Limited | 7.31 Million AUD | 56.832% |
| Actinogen Medical Limited | 21.31 Million AUD | 85.175% |
| Immuron Limited | 15.54 Million AUD | 79.681% |
| Argenica Therapeutics Limited | 16.37 Million AUD | 80.708% |